US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
iShares Biotechnology ETF
(NQ:
IBB
)
203.72
-1.67 (-0.81%)
Official Closing Price
Updated: 4:15 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares Biotechnology ETF
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
28
29
Next >
Market Predictions 2022: When Will Stocks Go Back Up?
↗
July 22, 2022
As investors look to jump back in, they’re asking, “when will stocks go back up?” It turns out that the bulls and bears are both right.
Via
InvestorPlace
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
↗
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
↗
July 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
↗
July 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
↗
July 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Biotech Stocks to Buy for Q3
↗
July 18, 2022
These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.
Via
InvestorPlace
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
↗
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
↗
July 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
↗
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
USD & EUR: Is This the Dollar’s Last Hurrah?
↗
July 13, 2022
The euro has been under pressure recently, with investors pulling their money out in favor of the haven currency—the US Dollar.
Via
Talk Markets
The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program
↗
July 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Strengthen Your Portfolio With Real Assets
↗
July 12, 2022
As we head into the second half of the year, it's essential to keep an eye on real assets. Real asset prices provide clues to what's happening in the global economy and can provide valuable insight.
Via
Talk Markets
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
↗
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
What Are the Corporate Bond Markets Telling Us?
↗
July 11, 2022
Keep an eye on these two corporate bonds ETFs to stay ahead of the curve in the stock market.
Via
Talk Markets
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
↗
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Walking The Fine Line - Five Indicators To Tell You When It Is Safe To Invest
↗
July 10, 2022
Daily, forecasters claim that we have probably started a recession (NOT) and that Energy prices will continue to climb (while they’ve declined over 10% in the past few weeks).
Via
Talk Markets
5 Best Stocks to Buy if You Have $100 to Spend
↗
July 10, 2022
My son became an investor this year, taking a job that pays more than his single, frugal lifestyle consumes. He asked me what stocks he might buy with
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
↗
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Best Biotech Stocks to Buy in July 2022
↗
July 08, 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.
Via
InvestorPlace
The 3 Best Retirement Stocks for Gen-Z Investors
↗
July 07, 2022
Older generations are showing their worry and providing a huge opportunity in the market's best retirement stocks for Gen-Z investors to buy
Via
InvestorPlace
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
↗
July 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Dislocation-Fundamentals Versus Price in Natural Gas
↗
July 06, 2022
Global demand for natural gas continues to skyrocket in the wake of Russia's invasion of Ukraine.
Via
Talk Markets
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
↗
July 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Did ARKK Bottom?
↗
July 05, 2022
ARKK may be the most extraordinary example of sheer brilliance and horrific money management combined.
Via
Talk Markets
3 Biotech Stocks to Sell Now
↗
July 05, 2022
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.
Via
InvestorPlace
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
↗
July 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Something Still Smells. Actions You Should Take Now!
↗
July 03, 2022
In June alone, the S&P 500, the Dow, the Nasdaq 100, and the Small-Cap indices were all down over 8% for the month. It wasn't pretty. Fortunately, it's halftime, and this can create an opportunity for...
Via
Talk Markets
Growth and Inflation Fears May Have Peaked: Top Trading Opportunities
↗
July 01, 2022
As bad as US equity markets have been in 2022, Chinese equity markets have had it much worse since early 2021.
Via
Talk Markets
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
↗
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
↗
July 01, 2022
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
28
29
Next >